{"id":"grup-2-dexametasona","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Mood changes"},{"rate":null,"effect":"Immunosuppression"},{"rate":null,"effect":"Osteoporosis (with chronic use)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone acts as a potent corticosteroid that inhibits pro-inflammatory cytokine production, reduces immune cell activation and migration, and suppresses both cellular and humoral immune responses. It is commonly used to manage inflammatory and autoimmune conditions by broadly dampening immune and inflammatory pathways.","oneSentence":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:47:34.132Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune conditions (specific indication for this Phase 3 trial unknown)"}]},"trialDetails":[{"nctId":"NCT06528444","phase":"PHASE3","title":"Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria y Biomédica de Alicante","startDate":"2024-10-01","conditions":"Influenza","enrollment":42}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Grup 2 dexametasona","genericName":"Grup 2 dexametasona","companyName":"Instituto de Investigación Sanitaria y Biomédica de Alicante","companyId":"instituto-de-investigaci-n-sanitaria-y-biom-dica-de-alicante","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors. Used for Inflammatory and autoimmune conditions (specific indication for this Phase 3 trial unknown).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}